Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Visit americanexpress.com to learn more. Getting preapproved for a credit card doesn't guarantee you'll be approved, but it can give you a better idea of your approval odds with no hard inquiry.
INDIANAPOLIS (Thursday, March 6, 2025) – Two-time NTT INDYCAR SERIES champion and back-to-back winner of the Indianapolis 500 presented by Gainbridge Josef Newgarden celebrated Southwest Airlines’ ...
Via early access, an individual healthcare system can support and fund treatment before European Medicines Agency (EMA) approval. As many as 18 European countries follow their own national procedures ...
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis
AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (Rinvoq; 15 mg, once ...
MediWound's first drug, NexoBrid®, is an FDA- and EMA-approved orphan biologic for eschar removal in deep partial-thickness and/or full-thickness thermal burns, significantly reducing the need for ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its February 2025 meeting. The European Commission is expected to announce a ...
Looking to open a new credit card but not sure if you'll get approved? There's a simple feature that many card issuers offer for free: pre-qualification. You can submit a prequalification form ...
of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of a label extension for IXCHIQ ®, Valneva's single-dose vaccine for the prevention of disease ...
SAN CARLOS, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results